Tien Liang BioTech Co., Ltd. (4127.TWO)
TWD 40.9
(0.25%)
TWD 40.9
(0.25%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 75.79 Million TWD | -20.19% |
| 2022 | 94.96 Million TWD | 55.81% |
| 2021 | 60.95 Million TWD | 15.92% |
| 2020 | 52.58 Million TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 70.79 Million TWD | -6.6% |
| 2024 Q2 | 71.24 Million TWD | 0.64% |
| 2023 Q2 | 95.86 Million TWD | -6.59% |
| 2023 FY | 75.79 Million TWD | -20.19% |
| 2023 Q1 | 102.62 Million TWD | 0.0% |
| 2023 Q4 | 75.79 Million TWD | -11.19% |
| 2023 Q3 | 85.35 Million TWD | -10.97% |
| 2022 Q4 | - TWD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Allied Biotech Corporation | 601.47 Million TWD | 87.398% |
| GeneFerm Biotechnology Co., Ltd. | 155.43 Million TWD | 51.236% |
| Easywell Biomedicals, Inc. | 42.17 Million TWD | -79.735% |
| TTY Biopharm Company Limited | 1.09 Billion TWD | 93.084% |
| Synmosa Biopharma Corporation | 1.59 Billion TWD | 95.257% |
| Orient EuroPharma Co., Ltd. | 1.09 Billion TWD | 93.083% |
| Center Laboratories, Inc. | 269.22 Million TWD | 71.847% |
| Orient Pharma Co., Ltd. | 233.97 Million TWD | 67.605% |
| InnoPharmax Inc. | 22.24 Million TWD | -240.763% |
| Johnson Chemical Pharmaceutical Works Co., Ltd. | 138.8 Million TWD | 45.395% |
| Excelsior Biopharma Inc. | 217.28 Million TWD | 65.116% |
| DV Biomed Co., Ltd. | 96.51 Million TWD | 21.467% |
| Foresee Pharmaceuticals Co., Ltd. | 126.79 Million TWD | 40.224% |
| Handa Pharmaceuticals, Inc. | - TWD | -Infinity% |
| UniPharma Co., Ltd. | 28.94 Million TWD | -161.871% |
| Anxo Pharmaceutical Co., Ltd. | 283.86 Million TWD | 73.298% |
| Alar Pharmaceuticals Inc. | - TWD | -Infinity% |
| Winston Medical Supply Co., Ltd. | 115.73 Million TWD | 34.51% |
| Mercury Biopharmaceutical Corporation | 10.07 Million TWD | -652.392% |
| Bioray Biotech Co., Ltd | 55.95 Million TWD | -35.471% |
| TSH Biopharm Corporation Limited | 118.39 Million TWD | 35.98% |